View drug registration information details.

Items	Registration information
ID	519
No	519
Brand Name	GLUCOVANCE 500 MG/2.5 MG
Ingredients	METFORMIN HYDROCHLORIDE 500 MG, GLIBENCLAMIDE 2.5 MG
Dosage Form	FILM COATED TABLET
Primary Packaging	PVC-PVDC BLISTER
Storage	STORE BELOW 30 C
Shelf Life	3 YEARS
Pack Size	BOX OF 30'S
Dispensing Category	Prescription only
ATC Classification	A10BD03
Pharmaceutical Class	ANTIDIABETE
Indications	TREATMENT OF TYPE 2 DIABETES IN ADULT, AS REPLACEMENT FOR PREVIOUS COMBINATION THERAPY WITH METFORMIN AND GLIBENCAMIDE IN PATIENTS WHOSE GLYCAEMIA IS STABLE AND WELL-CONTROLLED.
Contraindications	HYPERSENSITIVITY, TYPE 1 DIABETE, RENAL FAILURE OR RENAL DYSFUNCTION, ACUTE CONDITION WITH THE POTENTIAL TO ALTER RENAL FUNCTION SUCH AS: DYHYDRATION, SEVERE INFECTION, HEPATIC INSUFFICIENCY, ACUTE ALCOHOL INTOXICATION, ALCOHOLISM, PORPHYRIA, LACTATION
Side Effects	TASTE DISTURBANCE, GI DISORDER SUCH AS NAUSEA, VIMITTING, DIARRHEA, ABDOMINAL PAIN AND LOSS OF APPETITE, PRURITUS, URTICARIA, MACULOPAPULAR RASH
Unit Price
EDL	No
Description	ORANGE CAPSULE-SHAPED, BICONVEX FILM-COATED TABLETS WITH '2.5' ENGRAVED ON ONE SIDE
Note
License Owner	DKSH LAOS COMPANY LIMITED
Manufacturer	MERCK SANTE S.A.S
Country	FRANCE
Import Registration No	358 016-2
Import Registration Date	2001-10-18
Activity	CERTIFICATE RELEASED
Applied Date	2024-02-14
FDD Registration No	02 I 5047/21
FDD Registration Date	2024-06-22
Expiry Date	2027-06-21

Back to drug list